Page 36 | Certara

Publication

MIDD in Japan – Implementations, challenges and opportunities

In Japan, there has been a growing adoption of Model Informed Drug Development (MIDD) approaches…

CertaraMarch 12, 2025

On-Demand Webinar

Maximizing Clinical Efficiency: Simplifying SDTM Dataset workflow with the power of standardized metadata [APAC Webinar]

Lorem ipsum dolor sit amet consectetur. Donec diam risus volutpat tempor. Massa accumsan aliquam nibh…

CertaraMarch 11, 2025

Conference

DIA Europe 2026

- - Booth

CertaraMarch 10, 2025

Conference

AMCP 2025

- - Booth

CertaraMarch 10, 2025

Conference

BioIT World 2025

- - Booth

CertaraMarch 10, 2025

On-Demand Webinar

Model-Informed Drug Development in the Age of AI

Lorem ipsum dolor sit amet consectetur. Donec diam risus volutpat tempor. Massa accumsan aliquam nibh…

CertaraMarch 10, 2025

Conference

SCDM EMEA

- - Booth

CertaraMarch 10, 2025

Conference

2025 CDISC + TMF Europe Interchange

CertaraMarch 9, 2025

Fact Sheet

Nonclinical Development Science Services

CertaraMarch 7, 2025

Press Release

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions

March 5, 2025 McKemey joins Certara to accelerate growth of its strategic drug development solutions …

CertaraMarch 5, 2025

MIDD in Japan – Implementations, challenges and opportunities

Maximizing Clinical Efficiency: Simplifying SDTM Dataset workflow with the power of standardized metadata [APAC Webinar]

DIA Europe 2026

AMCP 2025

BioIT World 2025

Model-Informed Drug Development in the Age of AI

SCDM EMEA

2025 CDISC + TMF Europe Interchange

Nonclinical Development Science Services

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions

Newsletter sign up

Quick links

Solutions

Contact